- FDA summary of safety and effectiveness data (SSED). TriVisc®
TriVisc Package Insert
Ulucay, I. et al. Acta Orthop Traumatol Turc 2007;41: 337-342.
The use of arthroscopic debridement and viscosupplementation in
- Dıraçöglu, D. et al. J Back and Musculo Rehab. 2016;16: 53.
Single versus multiple dose hyaluronic acid: Comparison of the
Euflexxa® is a registered trademark of Ferring B.V. LLC.
VISCO-3® and Supartz® are trademarks of Seikagaku Corporation.
† The Adant® formulation is approved in 63 countries outside the US. Adant is manufactured by TEDEC-MEIJI FARMA and is authorized to be marketed and distributed under the trademark TriVisc.